AKRO - Akero Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AKRO is currently covered by 8 analysts with an average price target of $48.54. This is a potential upside of $20.45 (72.8%) from yesterday's end of day stock price of $28.09.

Akero Therapeutics's activity chart (see below) currently has 39 price targets and 55 ratings on display. The stock rating distribution of AKRO is 96.77% BUY and 3.23% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.37% with an average time for these price targets to be met of 249.44 days.

Highest price target for AKRO is $56, Lowest price target is $38, average price target is $48.54.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 11-Nov-2024. First documented stock forecast 15-Jul-2019.

Currently out of the existing stock ratings of AKRO, 30 are a BUY (96.77%), 1 are a HOLD (3.23%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$50

$21.91 (78.00%)

$50

6 days ago
(11-Nov-2024)

2/21 (9.52%)

$16.74 (50.33%)

495

Buy

4 months 28 days ago
(20-Jun-2024)

0/3 (0%)

$23.96 (159.31%)

Buy

$38

$9.91 (35.28%)

$60

6 months 2 days ago
(15-May-2024)

1/3 (33.33%)

$16.93 (80.35%)

106

Buy

$56

$27.91 (99.36%)

$59

6 months 4 days ago
(13-May-2024)

4/7 (57.14%)

$35.38 (171.58%)

496

Buy

$39

$10.91 (38.84%)

$83

1 years 1 months 5 days ago
(12-Oct-2023)

0/2 (0%)

$24.31 (165.49%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AKRO (Akero Therapeutics) average time for price targets to be met?

On average it took 249.44 days on average for the stock forecasts to be realized with a an average price target met ratio 35.37

Which analyst has the current highest performing score on AKRO (Akero Therapeutics) with a proven track record?

EDWARD NASH

Which analyst has the current lower performing score on AKRO (Akero Therapeutics) with a proven track record?

ELIANA MERLE

Which analyst has the most public recommendations on AKRO (Akero Therapeutics)?

Edward Nash works at CANACCORD and has 11 price targets and 7 ratings on AKRO

Which analyst is the currently most bullish on AKRO (Akero Therapeutics)?

Edward Nash with highest potential upside - $27.91

Which analyst is the currently most reserved on AKRO (Akero Therapeutics)?

Prakhar Agrawal with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?